TD COWEN Upgrades Canada Goose Holdings (GOOS)

TD COWEN upgraded Canada Goose Holdings (GOOS) to Buy on September 15, 2025, even as the average one-year price target of $13.80 suggests a slight 1.47% downside from its current $14.01. The company projects strong annual revenue growth of 17.90% to $1,613MM and non-GAAP EPS of $2.59. Institutional interest is growing, with 186 funds holding positions (up 5.08% QoQ) and average portfolio weight increasing by 16.83%, supported by a bullish 0.66 put/call ratio, despite a marginal 0.30% decrease in total institutional shares held.

Analysis

Canada Goose Holdings (GOOS) presents a compelling but mixed picture for investors, highlighted by a recent upgrade to 'Buy' from 'Hold' by TD COWEN. This positive analyst action is supported by strong forward-looking fundamentals, including a projected 17.90% increase in annual revenue to $1,613MM and a projected non-GAAP EPS of $2.59. Institutional sentiment appears to be strengthening, evidenced by a 5.08% quarterly increase in the number of funds holding the stock, a significant 16.83% increase in the average portfolio weight dedicated to GOOS, and a bullish put/call ratio of 0.66. Notably, major holders like Manufacturers Life Insurance and JADDX increased their portfolio allocations by over 28%, and Portolan Capital Management initiated a new position, signaling deepening conviction. However, these bullish signals are contrasted by a consensus one-year price target of $13.80, which represents a 1.47% downside from the last closing price, and a marginal 0.30% decrease in total shares owned by institutions. The wide forecast range, from $8.02 to $21.22, underscores significant divergence in analyst expectations.

Key Decisions for Investors

• Investors may consider the TD COWEN upgrade and strong 17.90% revenue growth projection as a catalyst, potentially justifying a long position despite the stock trading slightly above the average price target.
• It is prudent to weigh the bullish options market sentiment and increasing institutional portfolio allocations against the conflicting signal of a modest downside projected by the average price target, suggesting a potential valuation debate.
• Monitoring upcoming earnings reports will be critical to see if the company can deliver on its projected $2.59 non-GAAP EPS, which would likely resolve the current divergence between the analyst upgrade and the consensus price target.